Michael Greenstein

Biosynthetic origins of the polycyclic xanthone antibiotic, citreamicin

The biosynthesis of citreamicin 1 has been studied by feeding 13C- and 18O-labelled precursors to Micromonospora citrea cultures. 13C-NMR spectroscopic analysis of the enriched products demonstrated a labelling pattern indicating that the antibiotic is derived from a polyketide which undergoes rearrangement by a mechanism unique for xanthone biosynthesis.

Phenotypes conferred by the Bacillus subtilis recM13 mutation and the din23 fusion

The din23 fusion encodes a B. subtilis SOS-inducible regulatory region fused to the E. coli lacZ gene (Love et al., 1985). A strain encoding the din23 fusion and a recM13 allele showed low-level constitutive beta-galactosidase expression, was induced for beta-galactosidase production by DNA gyrase inhibitors but not by DNA-damaging agents, and was slightly induced by a variety of agents which do not normally induce the SOS regulon. The din23 fusion itself resulted in high levels of spontaneous prophage induction in wild-type, recM- and recA-hosts, despite the fact that the din23recM13 strain was not induced for beta-galactosidase production by DNA-damaging agents. The results suggest that the recM gene may be involved with the regulation of the RecA protease-mediated SOS response, while the din23 gene may be involved with the regulation of an alternative function which results in the cleavage of prophage repressor.